Tissue Addressed:
Teeth/ Dental Pulp
Technology Type:
Device
Regulatory Path:
510(k)
Current Phase:
- Phase 3: Verification
Principal Investigator(s):
Juan Taboas, PhD (Associate Professor)
University of Pittsburgh
Herb Ray, DMD (Associate Professor)
University of Pittsburgh
Clinical Need
Approximately 5 million procedures are performed in the USA each year to treat pulpitis of permanent teeth in the pediatric population. Children are often subject to multiple procedures because the standard of care is to stabilize the tooth until more definitive treatment can be performed when the child’s growth stops. The outcomes are unideal, because the whole tooth is not revitalized after pulp removal, resulting in tooth discoloration, loss of tooth structure, and limited (if any) tooth growth.
Solution
Vital-Dent is an acellular, resorbable hydrogel scaffold intended for revitalization of tooth pulp and maintenance of tooth vitality in immature permanent teeth treated with endodontic therapies. It is supplied as a powder in a single-use kit with sterile saline. The powder is rehydrated at the chairside using kit tools to make a clear liquid. The liquid is inserted into the instrumented canal space as would conventional sealers and sets in three minutes with a dental curing lamp to form the colorless Vital-Dent hydrogel. The tooth is then sealed with a bioceramic and restored with conventional techniques.
Competitive Advantage
Unlike current obturating materials, Vital-Dent is resorbable and promotes continued development of immature teeth, pulp revitalization and regenerative dentin, root strengthening, and long-term survival of the tooth. Vital-Dent eliminates difficulties of the only available revitalization procedure, revascularization therapy, with more consistent outcomes including root development, and a better fit with conventional clinic workflows including no phlebotomy and faster delivery.
ITP Support
Through the ITP program, biocompatibility and in vivo proof-of-concept of Vital-Dent were demonstrated. In collaboration with the Regulatory Core, design control process has been implemented, and regulatory strategy established. With the Market Assessment and Commercialization Cores, user needs and the indication for market entry were defined and a commercialization strategy, including business and funding plans, was developed.
Achievements
- SBIR awarded to VIC Foundry, based on ITP work
Regulatory Path
- 510(k)
Opportunities for Partnerships
- Seeking academic partnership in studies that promote adoption and advance therapy development
Key Publications & Patents
- Zaky et al. Effect of the periapical “inflammatory plug” on dental pulp regeneration: A histologic in vivo study. J Endod 2020
- PCT/US2019/023132 Regeneration of Vital Tooth Pulp
For any questions/interests in the projects, please contact us at
translationalrc@umich.edu